STUDY OF PENTRAXIN-3 LEVELS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AMONG EGYPTIAN PATIENTS

STUDY OF PLASMA PENTRAXIN 3 LEVELS AS A NOVEL MARKER VERSUS LIVER STIFFNESS FOR NONALCOHOLIC STEATOHEPATITIS IN EGYPTIAN PATIENTS

Serum Pentraxin 3 as a Biomarker of Hepatocellular Carcinoma in Egyptian Liver Cirrhotic Patients

Study of Serum Pentraxin-3 Level in Non-alcoholic Fatty Liver Disease and Its Affection by Concomitant Chronic Hepatitis B Virus Infection in Egyptian Patients

Association between serum level of pentraxin-3 and interleukin-40 with HCC disease in Egypt

Serum Paraoxonase-1 (PON1) Activity and Concentration: A new biomarker in Egyptian Patients with Liver Cirrhosis and Hepatocellular Carcinoma

EVALUATION OF PLATELET INDICES IN EGYPTIAN CIRRHOTIC PATIENTS

Study of the Role of D-dimer in The Prediction of Hepatorenal Syndrome in Cirrhotic Egyptian Patients

STUDY OF DES-GAMMA-CARBOXYPROTHROMBIN (DCP) LEVELS IN CHRONIC HEPATITIS C WITH OR WITHOUT HEPATOCELLULAR CARCINOMA (HCC) IN EGYPTIAN PATIENTS

Serum soluble cluster of differentiation 163 (sCD163), matrix metalloproteinase 9 (MMP9) and cytokeratin 18 (CK18) levels as biomarkers for liver fibrosis in Egyptian chronic hep